A systematic review and in silico study of potential genetic markers implicated in cases of overactive bladder - 22/12/22
Abstract |
Objective |
The contribution of genetic factors to the presence of an overactive bladder is recognized. This study aimed to (1) assemble and synthesize available data from studies assessing differential gene expression in patients with overactive bladder vs controls without overactive bladder and (2) determine possible correlations and functional pathways between genes.
Data Sources |
We searched PubMed, Ovid or Medline, and Wiley Cochrane Central Register of Controlled Trials databases between January 1, 2000, and December 15, 2021.
Study Eligibility Criteria |
Studies were included if gene expression was detected and quantified using molecular approaches performed on human bladder tissue specimens directly and excluded if the gene expression analysis was carried out from blood and urine specimens alone.
Methods |
A systematic review was completed to identify publications that reported differently expressed gene candidates among patients with overactive bladder vs healthy individuals. Gene networking connections and pathway analysis were performed employing Metascape software, where inputs were identified from our systematic review of differentially expressed genes in overactive bladder.
Results |
A total of 9 studies were included in the final analysis and 11 genes were identified as being up-regulated (purinergic receptor P2X 2 [P2RX2], smoothelin [SMTN], growth-associated protein 43 [GAP43], transient receptor potential cation channel subfamily M member 8 [TRPM8], cadherin 11 [CDH1], gap junction protein gamma 1 [GJC1], cholinergic receptor muscarinic 2 [CHRM2], cholinergic receptor muscarinic 3 [CHRM3], and transient receptor potential cation channel subfamily V member 4 [TRPV4]) or down-regulated (purinergic receptor P2X 2 [P2RX3] and purinergic receptor P2X 5 [P2RX5]) in patients with overactive bladder. Gene network analysis showed that genes are involved in chemical synaptic transmission, smooth muscle contraction, blood circulation, and response to temperature stimulus. Network analysis demonstrated a significant genetic interaction between TRPV4, TRPM8, P2RX3, and PR2X2 genes.
Conclusion |
Outcomes of this systematic review highlighted potential biomarkers for treatment efficacy and have laid the groundwork for developing future gene therapies for overactive bladder in clinical settings.
Le texte complet de cet article est disponible en PDF.Key words : gene expression, genomics, overactive bladder, systematic review, urge urinary incontinence
Plan
| The authors report no conflict of interest. |
|
| This study received no financial support. |
|
| This study was registered in the Open Science Framework (knfud) on July 1, 2020. |
Vol 228 - N° 1
P. 36 - janvier 2023 Retour au numéro
Article précédent
- Risk of endometrial cancer in asymptomatic postmenopausal women in relation to ultrasonographic endometrial thickness: systematic review and diagnostic test accuracy meta-analysis
- Salvatore Giovanni Vitale, Gaetano Riemma, Sergio Haimovich, Jose Carugno, Luis Alonso Pacheco, Tirso Perez-Medina, John Preston Parry, Peter Török, Jan Tesarik, Luigi Della Corte, Luigi Cobellis, Attilio Di Spiezio Sardo, Pasquale De Franciscis
- Now is the time to stand up for reproductive justice and abortion access
- Eve Espey, Sadia Haider, Joanne Stone, Cynthia Gyamfi-Bannerman, Jody Steinauer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?